Sonnet BioTherapeutics Holdings (SONN)
US Market

Sonnet BioTherapeutics Holdings (SONN) Cash flow


Sonnet BioTherapeutics Holdings Cash Flow

SONN's free cash flow for Q1 2024 was $-3.09M. For the 2024 fiscal year, SONN's free cash flow was decreased by $6.35M and operating cash flow was $-3.09M. See a summary of the company’s cash flow.
Cash Flow
Sep 23Sep 22Sep 21Sep 20Sep 19
Operating Cash Flow
$ -18.52M$ -21.34M$ -27.69M$ -22.55M$ -15.61M$ -2.23M
Investing Cash Flow
$ -443.25K$ -443.25K$ -896.48K$ -3.62K$ -76.18K$ 0.00
Financing Cash Flow
$ 20.28M$ 21.01M$ 4.01M$ 42.83M$ 23.01M$ 2.26M
Cash Flow From Discontinued Operation
Other Cash Adjustment Inside Changein Cash
End Cash Position
$ 23.71M$ 2.27M$ 3.05M$ 27.62M$ 7.35M$ 35.65K
Income Tax Paid Supplemental Data
Interest Paid Supplemental Data
----$ 0.00$ 99.89K
Issuance Of Capital Stock
$ 20.28M$ 21.01M--$ 19.07M$ 2.78M
Issuance Of Debt
$ -748.00$ -748.00-$ -20.44K$ 239.42K$ 338.49K
Repayment Of Debt
$ -748.00$ -748.00-$ -20.44K$ -110.73K$ -864.55K
Free Cash Flow
$ -18.52M$ -21.34M$ -27.69M$ -22.56M$ -15.69M$ -2.23M
Domestic Sales
Foreign Sales
Currency in USD

Sonnet BioTherapeutics Holdings Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis